Evidence map›Paper›PMID 32823631›Full record

ArticleJournal of clinical medicine2020

High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer.

Soon Auck Hong, Hye Won Hwang, Min Kyoon Kim, Tae Jin Lee, Kwangil Yim, Hye Sung Won, Der Sheng Sun, Eun Young Kim, Yoon Ho Ko

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. High CD8Frontiers in immunology · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Soon Auck HongDepartment of Pathology, College of Medicine, Chung-Ang University, Dongjak-gu, Seoul 06974, Korea.ORCID 0000-0002-7902-4608
Hye Won HwangDepartment of Pathology, College of Medicine, Chung-Ang University, Dongjak-gu, Seoul 06974, Korea.
Min Kyoon KimDepartment of Surgery, Chung-Ang University Hospital, College of Medicine, Chung-Ang University, Dongjak-gu, Seoul 06974, Korea.
Tae Jin LeeDepartment of Pathology, College of Medicine, Chung-Ang University, Dongjak-gu, Seoul 06974, Korea.
Kwangil YimDepartment of Hospital Pathology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul 06591, Korea.ORCID 0000-0001-8767-9033
Hye Sung WonDivision of Medical Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul 06591, Korea.
Der Sheng SunDivision of Medical Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul 06591, Korea.
Eun Young KimDepartment of Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul 06591, Korea.ORCID 0000-0002-8053-3186
Yoon Ho KoDivision of Medical Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul 06591, Korea.ORCID 0000-0002-2506-3740
Catholic University of Korea · KRChung-Ang University · KRThe Catholic University of Korea Uijeongbu St. Mary's Hospital · KRChung-Ang University Hospital · KR

Funding

National Research Foundation of Korea NRF-2018R1C1B5041752The Catholic University of Korea Uijeongbu St. Mary's Hospital Clinical Research Laboratory Foundation UJBCRL201701 and UJBCRL201743
6 · The paper itself

Abstract

CD8+ tumor-infiltrating lymphocytes (TILs) play a major role in antitumor immunity. High endothelial venules (HEVs) are related to diverse immune cells in solid tumors. We analyzed CD8+ and Foxp3+ TILs in combination with HEVs to determine their prognostic role in advanced gastric cancer (AGC). We enrolled 157 patients with AGC in this study. The densities of CD8+ TILs and Foxp3+ TILs were calculated using immunohistochemical staining. HEVs were evaluated by MECA-79 expression. HEVs were identified in 60 (38.2%) cases and was significantly associated with an increased number of CD8+ TILs (

Indexed as

CD8+ tumor-infiltrating lymphocytesgastric cancerhigh endothelial venuleprognosis

Identifiers

PMID32823631
PMCPMC7464373
OpenAlexW3048573322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.